Courtesy visit to YB Minister of Health on 11 January 2022 to underline PhAMA's support for government health initiatives towards a healthier Malaysia.

Topics discussed included foreign investments in Malaysia through member companies, medicine price transparency, access to innovative medicines, R&D and Malaysia's potential as a regional hub for clinical trials.

(Left to right): Mr Chin Keat Chyuan (President, PhAMA); Ms Chan Li Jin (Executive Director, PhAMA); Dato' Sri Mohd Shafiq Abdullah (Secretary General, MOH); YB Khairy Jamaluddin (Minister of Health); Tan Sri Dato' Hj. M. Ariffin Yusuf (Board of Director, PhAMA); Dr Sanjeev Panchal (Board of Director, PhAMA); Mr Chris Hamann (Board of Director, PhAMA)